Call Now

Recombinant Protein to Mus musculus (Mouse) Breast Cancer Susceptibility Protein 2 (BRCA2)

BRCA2; BRCC2; FACD; FAD; FAD1; FANCD; FANCD1; Breast Cancer 2,Early Onset; Breast Cancer Type 2 Susceptibility Protein; Fanconi anemia group D1 protein

DescriptionBreast Cancer Susceptibility Protein 2 (BRCA2)
Description Breast Cancer Susceptibility Protein 2 (BRCA2)
Catalog NumberV469Mu01
Organism SpeciesMus musculus (Mouse)
SourceProkaryotic expression
Expression SystemE. coli
Endotoxin Level <1.0 EU per 1 µg (determined by the LAL method)
Subcellular LocalizationCytoplasm, cytoskeleton, microtubule organizing center, centrosome.
Predicted Molecular Mass30.2kDa
Accurate Molecular Massn/a
Residues & TagsGlu2990~Ala3232 (Accession # P97929) with N-terminal His Tag
Buffer Formulation 20 mM Tris, 150 mM NaCl, pH 8.0, 5% Trehalose and Proclin 300.
Form Supplied Lyophilized powder
Purity Purity was assessed by SDS-PAGE (≥98%) and by HPLC.
SDS-PAGE SDS-PAGE image for Breast Cancer Susceptibility Protein 2 (BRCA2)
Isoelectric Point8.4
Applications Positive Control; Immunogen; SDS-PAGE; WB.
Storage Instruction We recommend a quick spin followed by reconstitution in water to a concentration of 0.1–1.0 mg/mL. This solution can then be diluted into other aqueous buffers and stored at 4°C for 1 week or at -20°C for future use.
Stability The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation testing at 37°C for 48 hours. No obvious degradation or precipitation was observed under the stated test conditions. The loss rate is less than 5% within the expiration date under appropriate storage conditions.
Notes For in vitro laboratory use only. Not for clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.